| Symptoms | Activity | Impacts | Overall |
Healthy individuals | | | | |
M (n=143) | 7.63±10.83 (6.28–8.99) | 7.10±10.48 (5.78–8.41) | 2.36±5.02 (1.73–2.99) | 4.84±6.30 (4.05–5.63) |
F (n=164) | 6.49±9.57 (5.46–7.51) | 13.13±15.73 (11.45–4.81) | 3.47±7.66 (2.65–4.29) | 7.14±8.83 (6.19–8.08) |
p‐value# | 0.18 | *** | * | *** |
COPD Patients | | | | |
M (n=275) | 22.55±18.01 (18.28–26.82) | 24.28±23.24 (18.75–29.81) | 12.82±15.94 (9.03–6.60) | 18.18±16.68 (14.21–22.15) |
F (n=78) | 12.43±13.9 (6.59–18.27) | 19.52±25.45 (8.83–30.20) | 8.05±13.11 (2.54–13.55) | 12.55±15.61 (6.00–19.10) |
p‐value# | ** | 0.42 | 0.21 | 0.17 |
Asthma | | | | |
M (n=39) | 32.82±25.46 (20.34–45.28) | 29.24±25.91 (16.56–41.92) | 16.45±16.92 (8.16–24.74) | 23.15±19.52 (13.6–2.70) |
F (n=43) | 26.34±20.42 (16.19–36.49) | 29.53±26.69 (15.26–43.80) | 15.61±19.53 (5.89–25.33) | 21.68±20.68 (11.39–1.97) |
p‐value# | 0.44 | 0.98 | 0.89 | 0.84 |